Friday , October 22 2021

Aphria announces that short vendor claims will provide rebuttal line-on-line



[ad_1]

One of Canada's largest cannabis producers, Aphria's CEO, Vic Neufeld, said the company will discuss the claims made in the short-seller report online.

Tyler Anderson / Naitonal Post / Tyler Anderson / National Message

Leamington's cannabis maker, Aphria's CEO, is under siege from short-sellers claiming that the back-sellers have enriching content – the company will publish a report to appeal each week.

Vic Neufeld said Aphria's response on Monday was facing charges that focused on the company's new acquisitions in Latin America.

Neufeld told Star on Friday that "20-day some claims, line-by-line, point-to-real pictures with pictures, real pictures – we called the acquisition of LATAM assets." ”Every point will be very informative and will keep true light on the story.“

He said the clash would probably be released on Wednesday. Aphria announced on Thursday that it has appointed an independent committee to review the company's acquisition of shares in Latin America and to verify its independence.

Neufeld said that Liberty Health Sciences, the target of a second round of claims by Aphria, would probably release its response on Monday.

The court said the possibility of filing a lawsuit prevented it from obtaining specific details of allegations until next week's official responses.

He said, "I won't hide." Gerçek To make sure we're not pre-selective, we've focused on being true to all the facts that we have explained and that we have to be revealed. . "

However, he added that no further judicial proceedings would prove to be unproven.

This was one of many claims, called Quintessential Capital Management and a li shell game y and # black hole H from the forensic analysis company Hindenburg Research, which targeted Aphria on Monday.

Both Quintessential and Hindenburg were reported to have short-term Aphria stockpiles. In the event of a security price drop, the shorter seller may gain.

They claim that Aphria's funds are directed towards inflated investments regulated by insiders and their recent transactions in Latin America are worthless. Hindenburg claimed that the Jamaican purchase office, a formal $ 145 million office for Aphria, was 145 an abandoned building sold by the bank earlier this year H.

The company also claims that the $ 50 million purchase of Argentina, which claims Aphria sold $ 11 million in 2017, is only $ 430,000.

Hindenburg, Liberty launched a second attack attack focused on a Florida property purchased by Health Sciences. Forensic analysis firm claims that buyers, rather than just buying goods, buy it from a newly established entity, and that this situation is trapped around $ 5 million in six days. Hindenburg claims that this was done under the supervision of Neufeld.

Hindenburg claims that sel anonymous individuals bought $ 0.001 special placements at $ 242 million of Freedom sat, just a day after Aphria announced its plan to buy shares at 208 times the price.

The Hindenburg report also reported that Neufeld paid 280,450 shares, but in fact it took over more than 2.4 million people. Neufeld said on Friday that a report said this, but it was a mistake on Thursday.

2,4 280.450 shares of the shares I purchased were expected to be more than 2.4 million for any reason. That, in Hindenburg, 2.1 million shares in a free way I gave the suspicion that I bought. Burg He said. Hat This is a mistake made by Liberty Health Sciences and our legal company. Now they've fixed it and they've indicated the correction. "

Neufeld said Aphria was still ere going through the pros and cons hala of filing a lawsuit against the reports.

“In the end of any case, will we understand that we will succeed in everything? What I don't want to do is spend time on shareholder's money and management management on something that could result in zero realization. So we didn't say no, but we didn't say yes. "

I [email protected]

twitter.com/winstarwilhelm

[ad_2]
Source link